220 related articles for article (PubMed ID: 8380426)
1. Short echo time proton MR spectroscopic imaging.
Posse S; Schuknecht B; Smith ME; van Zijl PC; Herschkowitz N; Moonen CT
J Comput Assist Tomogr; 1993; 17(1):1-14. PubMed ID: 8380426
[TBL] [Abstract][Full Text] [Related]
2. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.
Poptani H; Gupta RK; Roy R; Pandey R; Jain VK; Chhabra DK
AJNR Am J Neuroradiol; 1995 Sep; 16(8):1593-603. PubMed ID: 7502961
[TBL] [Abstract][Full Text] [Related]
3. Proton MR spectroscopy in patients with neurofibromatosis type 1: evaluation of hamartomas and clinical correlation.
Castillo M; Green C; Kwock L; Smith K; Wilson D; Schiro S; Greenwood R
AJNR Am J Neuroradiol; 1995 Jan; 16(1):141-7. PubMed ID: 7900583
[TBL] [Abstract][Full Text] [Related]
4. Differences in metabolic and morphological reactions after radiation therapy: proton NMR spectroscopy and imaging of patients with intracranial tumors.
Ikehira H; Miyamoto T; Yasukawa T; Obata T; Katoh H; Koga M; Yoshikawa K; Yoshida K; Tateno Y
Radiat Med; 1995; 13(5):199-204. PubMed ID: 8848553
[TBL] [Abstract][Full Text] [Related]
5. Proton MR spectroscopy of gadolinium-enhanced multiple sclerosis plaques.
Narayana PA; Wolinsky JS; Jackson EF; McCarthy M
J Magn Reson Imaging; 1992; 2(3):263-70. PubMed ID: 1627860
[TBL] [Abstract][Full Text] [Related]
6. Quantitative proton magnetic resonance spectroscopy of focal brain lesions.
Wilken B; Dechent P; Herms J; Maxton C; Markakis E; Hanefeld F; Frahm J
Pediatr Neurol; 2000 Jul; 23(1):22-31. PubMed ID: 10963966
[TBL] [Abstract][Full Text] [Related]
7. Incorporation of lactate measurement in multi-spin-echo proton spectroscopic imaging.
Duyn JH; Frank JA; Moonen CT
Magn Reson Med; 1995 Jan; 33(1):101-7. PubMed ID: 7891522
[TBL] [Abstract][Full Text] [Related]
8. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance spectroscopic imaging for visualization of the infiltration zone of glioma.
Stadlbauer A; Buchfelder M; Doelken MT; Hammen T; Ganslandt O
Cent Eur Neurosurg; 2011 May; 72(2):63-9. PubMed ID: 20635312
[TBL] [Abstract][Full Text] [Related]
10. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
[TBL] [Abstract][Full Text] [Related]
11. Mapping extracellular pH in rat brain gliomas in vivo by 1H magnetic resonance spectroscopic imaging: comparison with maps of metabolites.
García-Martín ML; Hérigault G; Rémy C; Farion R; Ballesteros P; Coles JA; Cerdán S; Ziegler A
Cancer Res; 2001 Sep; 61(17):6524-31. PubMed ID: 11522650
[TBL] [Abstract][Full Text] [Related]
12. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.
Stadlbauer A; Moser E; Gruber S; Buslei R; Nimsky C; Fahlbusch R; Ganslandt O
Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the response of metastatic brain tumors to stereotactic radiosurgery by proton magnetic resonance spectroscopy, 201TlCl single-photon emission computerized tomography, and gadolinium-enhanced magnetic resonance imaging.
Kimura T; Sako K; Tanaka K; Gotoh T; Yoshida H; Aburano T; Tanaka T; Arai H; Nakada T
J Neurosurg; 2004 May; 100(5):835-41. PubMed ID: 15137602
[TBL] [Abstract][Full Text] [Related]
14. Proton magnetic resonance spectroscopy and gadolinium-DTPA perfusion imaging of asymptomatic MRI white matter lesions.
Oppenheimer SM; Bryan RN; Conturo TE; Soher BJ; Preziosi TJ; Barker PB
Magn Reson Med; 1995 Jan; 33(1):61-8. PubMed ID: 7891536
[TBL] [Abstract][Full Text] [Related]
15. 1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast.
Sijens PE; van den Bent MJ; Nowak PJ; van Dijk P; Oudkerk M
Magn Reson Med; 1997 Feb; 37(2):222-5. PubMed ID: 9001146
[TBL] [Abstract][Full Text] [Related]
16. Proton MR spectroscopy and MR imaging in acute and chronic multiple sclerosis--ringlike appearances in acute plaques.
Landtblom AM; Sjöqvist L; Söderfeldt B; Nyland H; Thuomas KA
Acta Radiol; 1996 May; 37(3 Pt 1):278-87. PubMed ID: 8845254
[TBL] [Abstract][Full Text] [Related]
17. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
18. (1)H spectroscopic imaging of human brain at 3 Tesla: comparison of fast three-dimensional magnetic resonance spectroscopic imaging techniques.
Zierhut ML; Ozturk-Isik E; Chen AP; Park I; Vigneron DB; Nelson SJ
J Magn Reson Imaging; 2009 Sep; 30(3):473-80. PubMed ID: 19711396
[TBL] [Abstract][Full Text] [Related]
19. Proton MR spectroscopy and magnetization transfer ratio in multiple sclerosis: correlative findings of active versus irreversible plaque disease.
Kimura H; Grossman RI; Lenkinski RE; Gonzalez-Scarano F
AJNR Am J Neuroradiol; 1996 Sep; 17(8):1539-47. PubMed ID: 8883654
[TBL] [Abstract][Full Text] [Related]
20. Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy.
Cianfoni A; Niku S; Imbesi SG
AJNR Am J Neuroradiol; 2007 Feb; 28(2):272-7. PubMed ID: 17296993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
